ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 44 filers reported holding ACRIVON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,319 | – | 138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sands Capital Ventures, LLC | 1,652,605 | $15,798,904 | 4.67% |
Perceptive Advisors | 3,007,858 | $28,755,122 | 0.96% |
RA Capital Management | 4,810,508 | $45,988,456 | 0.90% |
NEA Management Company, LLC | 430,252 | $4,113,209 | 0.32% |
DAFNA Capital Management LLC | 76,852 | $734,705 | 0.23% |
AAF Wealth Management, LLC | 10,678 | $102,082 | 0.07% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 105,000 | $1,003,800 | 0.02% |
MARSHALL WACE, LLP | 597,469 | $5,711,804 | 0.01% |
FEDERATED HERMES, INC. | 226,375 | $2,164,145 | 0.01% |
EXCHANGE TRADED CONCEPTS, LLC | 9,919 | $94,826 | 0.00% |